Thioridazine-d3 5-Sulfoxide is a deuterated derivative of thioridazine, which is an antipsychotic medication primarily used to treat schizophrenia and other mental health disorders. The "d3" designation indicates that the compound contains three deuterium atoms, which are isotopes of hydrogen, enhancing its stability and allowing for specific applications in research, particularly in pharmacokinetics and metabolic studies. The sulfoxide functional group in this compound suggests the presence of a sulfur atom bonded to an oxygen atom, which can influence the compound's reactivity and biological activity. Thioridazine itself is known for its sedative effects and potential side effects, including cardiovascular issues and extrapyramidal symptoms. The sulfoxide modification may alter its pharmacological profile, potentially affecting its efficacy and safety. As with any chemical substance, handling should be conducted with care, adhering to safety protocols, and understanding its implications in both therapeutic and research contexts.

Thioridazine-d3 5-Sulfoxide

1330076-56-6: Thioridazine-d3 5-Sulfoxide is a deuterated derivative of thioridazine, which is an antipsychotic medication primarily used to treat schizophrenia and other mental health disorders. The "d3" designation indicates that the compound contains three deuterium atoms, which are isotopes of hydrogen, enhancing its stability and allowing for specific applications in research, particularly in pharmacokinetics and metabolic studies. The sulfoxide functional group in this compound suggests the presence of a sulfur atom bonded to an oxygen atom, which can influence the compound's reactivity and biological activity. Thioridazine itself is known for its sedative effects and potential side effects, including cardiovascular issues and extrapyramidal symptoms. The sulfoxide modification may alter its pharmacological profile, potentially affecting its efficacy and safety. As with any chemical substance, handling should be conducted with care, adhering to safety protocols, and understanding its implications in both therapeutic and research contexts.

Applications A labelled metabolite of Thioridazine (THD-5-SO). Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Niedzwiecki, D., et al.: J. Pharmacol. Exp. Ther., 250, 126 (1989), Eap, C., et al.: Ther. Drug Monit., 13, 356 (1991), Shah, P., et al.: J. Pharm. Sci., 81, 309 (1992), Eap, C., et al.: J. Pharm. Biomed. Anal., 11, 451 (1993), Blake, B., et al.: Xenobiotica, 25, 337 (1995),

CAS 1330076-56-6

Thioridazine-d3 5-Sulfoxide

Thioridazine-d3 5-Sulfoxide

Ref: TR-T368817